...
首页> 外文期刊>Neuropsychobiology >Norepinephrine and serotonin transporter genes: impact on treatment response in depression.
【24h】

Norepinephrine and serotonin transporter genes: impact on treatment response in depression.

机译:去甲肾上腺素和血清素转运蛋白基因:对抑郁症治疗反应的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: The norepinephrine transporter (NET) and serotonin transporter (5-HTT) genes constitute promising candidate genes in major depression. Seven polymorphisms in the promoter, intronic and exonic region of the NET gene, as well as serotonin-transporter-linked promoter region (5-HTTLPR) and 5-HTT rs25531 polymorphisms were analyzed with respect to antidepressant treatment response with particular attention to gender effects and subtypes of melancholic or anxious depression. METHODS: 252 unrelated Caucasian patients (f = 142; m = 110) with major depression were genotyped for NET and 5-HTT polymorphisms. Genotype effects on Hamilton Depression Rating Scale score changes over 6 weeks of antidepressant treatment were analyzed using analysis of covariance with repeated measures. RESULTS: There was no effect of any of the 7 investigated NET, or the two 5-HTT polymorphisms, on the overall treatment response. An additional -/CT insertion/deletion (ins/del) polymorphism (rs58532686), however, was significantly associated with melancholic depression, with a better response in 12 patients carrying the deletion. Stratification for anxious versus nonanxious depression revealed a significantly detrimental effect of the less active 5-HTTLPR S allele (p = 0.007) and 5-HTTLPR/5-HTT rs25531 haplotypes on treatment response in patients with anxious depression. CONCLUSION: The present findings do not support a major impact of the NET and 5-HTT genes on antidepressant treatment response in major depression per se. However, there might be an impact of a -/CT ins/del polymorphism in the enhancer domain of the NET gene on treatment response in melancholic depression, which remains to be functionally investigated in future studies. The observed significant influence of the 5-HTT gene variation on antidepressant treatment in anxious depression points to anxious depression as a potential diagnostic entity of its own, requiring specific diagnostic and therapeutic attention.
机译:背景/目的:去甲肾上腺素转运蛋白(网)和血清素转运蛋白(5-HTT)基因构成主要抑郁症的候选基因。在抗抑郁治疗反应的情况下分析了净基因的启动子,内肠和偏振区域的七种多态性,以及血清素 - 转运蛋白连接的启动子区(5-HTTLPR)和5-HTT / rs25531多态性,特别注意性别效应和忧郁或焦虑抑郁症的亚型。方法:252例无关的白种人患者(F = 142; m = 110),主要抑郁症是净和5-HTT多态性的基因分型。使用协方差与重复措施分析,分析了对捕发抑制评级评分评分评分评分变化的基因型对抗抑郁治疗的影响。结果:在整个治疗反应中没有7种调查网络或两种5-HTT多态性中任一项的影响。然而,额外的 - / CT插入/删除(INS / DEL)多态性(RS58532686)与忧郁抑郁显着相关,在12名患有缺失的患者中具有更好的反应。焦虑与饥饿患者急剧抑郁症患者治疗响应的较低活性5-HTTLPS等位基因(P = 0.007)和5-HTTLPR / 5-HTT rs25531单倍型对治疗反应的显着不利影响。结论:本研究结果不支持净和5-HTT基因对主要抑郁症抗抑郁治疗反应的主要影响。然而,在近期抑郁症对净基因的增强剂结构域中的A / CT INS / DEL多态性可能存在影响忧郁抑郁症的治疗反应,这在未来的研究中仍有待在功能上调查。观察到5-HTT基因变异对焦急抑郁症抗抑郁药治疗的显着影响,焦虑的抑制抑郁症作为其自身的潜在诊断实体,需要具体的诊断和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号